Cata-Kor NAD+ Advanced Earns Alkemist Assured(TM) Approval

Cata-Kor's High-Dose NAD+ Advanced Supplement Passes Third-Party Testing for Ingredient Identity and Label AccuracyMiami, Florida--(Newsfile Corp. - October 22, 2025) - Cata-Kor, a U.S.-based ...

Acute Ischemic Stroke Pipeline Market Research Report 2025: Opportunities with 25+ Drugs in ...

The Acute Ischemic Stroke pipeline presents opportunities with 25+ drugs in development across various stages, emphasizing innovative treatments like Prourokinase recombinant, RNS60, and AVLX-144. Key ...